Surgical approach and outcomes of empyema patients in Prof. Ngoerah Hospital: a single-center retrospective observational study
Main Article Content
Keywords
empyema, surgical outcomes, pleural infection, retrospective study
Abstract
Background: The number of patients with empyema thoracis is increasing with time despite rigorous prevention methods such as vaccination and antibiotic use. Surgical interventions are often required for advanced cases, though outcomes may differ due to other factors and staging. This study retrospectively evaluates the surgical management and outcomes of patients with empyema.
Methods: We performed a retrospective observational study at Cardiothoracic and Vascular Surgery Divison in Prof Ngoerah Hospital from January 2019 to December 2021. Patients were diagnosed with imaging and pleural fluid analysis and referred to the cardiothoracic and vascuar surgery department. 22 patients were included in this study and had their demographic data, comorbidities, surgical interventions, and outcomes analyzed. An range of interventions was performed such as open thoracotomy, video-assisted thoracoscopic surgery (VATS), or as a combination. Outcomes assessed included the need for repeat surgery, length of hospital stay (LOS), and ICU stay. All data were analyzed using IBM® SPSS 26.0 using univariate descriptive analysis.
Results: Out of the 22 patients (mean age 42.55 years), there were more males than females (68.2%), and half of them came into the hospital with complex empyema (Light’s Category 7). Open thoracotomy was the most common intervention (54.5%), followed by VATS (31.8%). Most patients (81.8%) did not require repeat surgeries. LOS ranged from 2 to 48 days (mean: 17.18), and ICU stays averaged 5.24 days. Comorbidities such as pneumonia (31.8%), tuberculosis (18.2%), and diabetes mellitus (13.6%) were seen.
Conclusion: This study highlights possible barriers in providing optimal care to patients with empyema and its comorbidities and includes late diagnosis for favorable surgical outcomes. This issue is particularly significant, as a substantial proportion of patients continue to present with advanced stages of empyema.
References
2. Ahmed AEH, Yacoub TE. Empyema thoracis. Clin Med Insights Circ Respir Pulm Med. 2010;4:1–8. Available from: https://pubmed.ncbi.nlm.nih.gov/21157522
3. Kwon YS. Pleural infection and empyema. Tuberc Respir Dis (Seoul). 2014/04/25. 2014;76(4):160–2. Available from: https://pubmed.ncbi.nlm.nih.gov/24851128
4. Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008;15(2):85–9. Available from: https://pubmed.ncbi.nlm.nih.gov/18354748
5. Indonesian Ministry of Helath. Basic Helath Research 2022. Jakarta; 2022.
6. Brims FJH, Lansley SM, Waterer GW, Lee YCG. Empyema thoracis: new insights into an old disease. Eur Respir Rev. 2010;19(117):220–8. Available from: https://pubmed.ncbi.nlm.nih.gov/20956197
7. Veerappan Periasamy A. Outcome and mortality analysis in complicated parapneumonic effusion and empyema. Int J Clin Trials. 2017;4(4):176. Available from: http://dx.doi.org/10.18203/2349-3259.ijct20174208
8. Kobashi Y, Mouri K, Yagi S, Obase Y, Oka M. Clinical Analysis of Cases of Empyema Due to <i>Streptococcus milleri</i> Group. Jpn J Infect Dis. 2008;61(6):484–6. Available from: http://dx.doi.org/10.7883/yoken.jjid.2008.484
9. Falguera M, Carratalà J, Bielsa S, García-Vidal C, Ruiz-González A, Chica I, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173–9. Available from: http://dx.doi.org/10.1183/09031936.00000211
10. Herdiman H. DIagnosis and treatment of empyema. Hum Care J. 2022;7(1):21. Available from: http://dx.doi.org/10.32883/hcj.v7i1.1569
11. Dusemund F, Weber MD, Nagel W, Schneider T, Brutsche MH, Schoch OD. Characteristics of Medically and Surgically Treated Empyema Patients: A Retrospective Cohort Study. Respiration. 2013;86(4):288–94. Available from: http://dx.doi.org/10.1159/000353424
12. Shiraishi Y. Surgical treatment of chronic empyema. Gen Thorac Cardiovasc Surg. 2010;58(7):311–6. Available from: http://dx.doi.org/10.1007/s11748-010-0599-6
13. Light RW. A New Classification of Parapneumonic Effusions and Empyema. Chest. 1995;108(2):299–301. Available from: http://dx.doi.org/10.1378/chest.108.2.299
14. Tian P, Qiu R, Wang M, Xu S, Cao L, Yang P, et al. Prevalence, Causes, and Health Care Burden of Pleural Effusions Among Hospitalized Adults in China. JAMA Netw open. 2021;4(8):e2120306–e2120306. Available from: https://pubmed.ncbi.nlm.nih.gov/34374774
15. Wen P, Wei M, Han C, He Y, Wang M-S. Risk factors for tuberculous empyema in pleural tuberculosis patients. Sci Rep. 2019;9(1):19569. Available from: https://pubmed.ncbi.nlm.nih.gov/31863026
16. Tsai Y-M, Gamper N, Huang T-W, Lee S-C, Chang AH. Predictors and Clinical Outcomes in Empyema Thoracis Patients Presenting to the Emergency Department Undergoing Video-Assisted Thoracoscopic Surgery. J Clin Med. 2019;8(10):1612. Available from: https://pubmed.ncbi.nlm.nih.gov/31623408
17. Menéndez R, Cremades MJ, Martínez-Moragón E, Soler JJ, Reyes S, Perpiñá M. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J. 2003;22(4):643–8. Available from: http://dx.doi.org/10.1183/09031936.03.00026103
